← back to search

Edel A. O’Toole

Queen Mary University of London · GB
Area of research
Cell Biology · Immunology and Allergy
Research interest
Research interests include Skin and Cellular Biology Research, Cell Adhesion Molecules Research, Dermatology and Skin Diseases, and Autoimmune Bullous Skin Diseases.
h-index
52
citations
9,231
works
354
NIH funding
primary concept
Medicine
email

Recent publications

ILVEN revisited: A mosaic spectrum rather than a single disease.
2026cited by 0position: contributordoi
Unravelling the threads of central centrifugal cicatricial alopecia
Journal of Investigative Dermatology 2026cited by 0position: contributordoi
A single-cell and spatial genomics atlas of human skin fibroblasts reveals shared disease-related fibroblast subtypes across tissues
Nature Immunology 2025cited by 31position: middledoi
Nonsyndromic epidermal differentiation disorders: a new classification toward pathogenesis-based therapy.
2025cited by 22position: contributordoi
Syndromic epidermal differentiation disorders: a new classification toward pathogenesis-based therapy.
2025cited by 20position: contributordoi
A single-cell and spatial genomics atlas of human skin fibroblasts reveals shared disease-related fibroblast subtypes across tissues.
2025cited by 19position: contributordoi
Palmoplantar epidermal differentiation disorders: a new classification toward pathogenesis-based therapy.
2025cited by 18position: contributordoi
Rare disease gene association discovery in the 100,000 GenomesProject
Nature 2025cited by 16position: middledoi
A proposal for a new pathogenesis-guided classification for inherited epidermal differentiation disorders.
2025cited by 14position: contributordoi
Rare disease gene association discovery in the 100,000 Genomes Project.
2025cited by 9position: contributordoi
Management of congenital ichthyoses: guidelines of care: Part one: 2024 update.
2025cited by 7position: contributordoi
Itching for innovation: the role of aryl hydrocarbon receptor agonists as a future therapy for atopic dermatitis.
2025cited by 3position: contributordoi
Management of congenital ichthyoses: guidelines of care: Part two: 2024 update.
2025cited by 2position: contributordoi
Pachyonychia Congenita Project: Advancing Research and Drug Development through Collaboration.
2025cited by 1position: contributordoi
Celebrating 20 Years of the International Pachyonychia Congenita Consortium.
2025cited by 1position: contributordoi
<i>GLI2</i> and <i>FLNB</i> Define Periocular Morphoeic Basal Cell Carcinoma.
2025cited by 0position: contributordoi
Scabies Infestations.
2025cited by 0position: contributordoi
Biologics in congenital ichthyosis: an incomplete fix.
2025cited by 0position: contributordoi
Evaluation of the Foot Function Index in pachyonychia congenita.
2025cited by 0position: contributordoi
Weekly Intraperitoneal Injection of Tamoxifen in an Inducible In Vivo Model of Junctional Epidermolysis Bullosa Generates Early and Advanced Disease Phenotypes.
2025cited by 0position: contributordoi
The Importance of Shared Patient Voices in Advancing Science for Genodermatoses on a Global Scale.
2025cited by 0position: contributordoi
Non-pachyonychia congenita conditions in the International Pachyonychia Congenita Research Registry.
2025cited by 0position: contributordoi
A prenatal skin atlas reveals immune regulation of human skin morphogenesis
Nature 2024cited by 87position: middledoi
A prenatal skin atlas reveals immune regulation of human skin morphogenesis.
2024cited by 64position: contributordoi
Pachyonychia Congenita: A Research Agenda Leading to New Therapeutic Approaches
Journal of Investigative Dermatology 2024cited by 14position: contributordoi
Th2 response drives itch in dystrophic epidermolysis bullosa pruriginosa: A case-control study.
2024cited by 8position: contributordoi
Upregulation of keratin 15 is required for varicella-zoster virus replication in keratinocytes and is attenuated in the live attenuated vOka vaccine strain.
2024cited by 6position: contributordoi
QSOX2 Deficiency-induced short stature, gastrointestinal dysmotility and immune dysfunction.
2024cited by 6position: contributordoi
A single cell and spatial genomics atlas of human skin fibroblasts in health and disease
2024cited by 4position: contributordoi
Loss-of-function FLG mutations are associated with reduced history of acne vulgaris in a cohort of patients with atopic eczema of Bangladeshi ancestry in East London.
2024cited by 2position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 30 papers (2019–2026)Juliette Mazereeuw-Hautier · Centre National de la Recherche Scientifique10 papers (2019–2025)Matthias Schmuth · Innsbruck Medical University9 papers (2019–2025)Amy S. Paller · Duke University8 papers (2020–2025)David Kelsell · Queen Mary University of London8 papers (2019–2025)Masashi Akiyama · Tama University6 papers (2025–2025) · 6 papers (2025–2025)Céline Granier Tournier · Université Toulouse III - Paul Sabatier6 papers (2025–2025)Janice Schwartz · Pachyonychia Congenita Project5 papers (2024–2025)Matthew Caley · Springer Nature5 papers (2020–2025)Lloyd Steele · Wellcome Sanger Institute5 papers (2020–2023)John A. McGrath · University of Minnesota Medical Center4 papers (2015–2024)Bjorn R Thomas · National Health Service4 papers (2022–2023)Akemi Ishida‐Yamamoto · Asahikawa Medical College Hospital4 papers (2025–2025)Alain Hovnanian · Rockefeller University4 papers (2024–2025)Eli Sprecher · Boston Children's Hospital4 papers (2014–2024)Ángela Hernández-Martín · Hospital Infantil Universitario Niño Jesús3 papers (2019–2025)A. Gostyński · Maastricht University Medical Centre3 papers (2025–2025)Marianne de Brito · Queen Mary University of London3 papers (2024–2024)Rebecca L McCarthy · Barts and The London School of Medicine and Dentistry Blizard Institute3 papers (2024–2026)